Apple has decided to exclude the blood oxygen feature from the Apple Watch Series 9 and Ultra 2, aiming to continue selling these premium watches while navigating an ongoing patent dispute with health tech firm Masimo.
Customers opting for these versions will still encounter mentions of the blood oxygen feature, but upon tapping, they will receive a message indicating its unavailability.
Back in January 2023, a US judge determined that Apple’s blood oxygen sensing system violates Masimo’s patents. Consequently, in October, the US International Trade Commission issued an order barring the importation of the watch.
“Apple’s appeal is ongoing, and we believe the US Court of Appeals for the Federal Circuit should reverse the USITC’s decision. We strongly disagree with the USITC decision and resulting orders,” Apple conveyed in a statement released late Wednesday.
Importantly, these modifications to the Apple Watch Series 9 and Ultra 2 do not impact the Apple Watch SE, which lacks a blood oxygen feature.